CEO Steve Lydeamore to Present at AusBiotech 2020
Sydney, Oct 9, 2020 AEST (ABN Newswire) - Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.
AusBiotech + Invest 2020 is dedicated to consolidating the sector's growth, and our 2020 conference will once again present issues critical to industry.
Providing a new level of global insight and perspective, keynotes, panel discussions and key themes will cover:
- The global biotech response to COVID-19
- Australia's life sciences industry unites through COVID-19
- The business of biotech
- Regulatory innovation
- Clinical trials
- Medtech and digital health
- Global pharma talks: Search, evaluation and venture investment
- Regenerative medicine and cell therapies
- Therapeutics and personalised medicine
- Health meets agriculture
- Early stage investment
To Register for AusBiotech, please visit:
https://www.abnnewswire.net/lnk/O30B12B3
To view the AusBiotech 2020 Program, please visit:
https://abnnewswire.net/lnk/64ZXQ2TT
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
